Literature DB >> 6822562

Transcription of adenovirus-2 major late promoter inhibited by monoclonal antibody directed against RNA polymerases IIO and IIA.

M E Dahmus, C Kedinger.   

Abstract

Monoclonal antibody directed against RNA polymerases IIO and IIA completely inhibits specific transcription from the major late promoter of adenovirus-2. At comparable antibody concentrations, only a slight inhibition of polymerase III transcription of VA RNA I is observed. Inhibition of polymerase II transcription is specific for monoclonal IgM directed against RNA polymerase II. High concentrations of control IgM do not inhibit transcription. Specific transcription from the conalbumin and ovalbumin promoters is also inhibited by polymerase-specific monoclonal IgM but not control IgM. These results suggest that the in vitro transcription of the conalbumin, ovalbumin, and adenovirus-2 major late promoter is catalyzed by RNA polymerase(s) IIO and/or IIA but not RNA polymerase IIB. However, transcription from calf thymus DNA, known to contain nicks, is not inhibited by polymerase specific monoclonal antibody. Thus, the monoclonal antibody does not interfere with initiation or elongation of RNA polymerase from nonpromoter sites but does appear to selectively inhibit transcription from promoter sites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822562

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The C-terminal domain of the largest subunit of RNA polymerase II and transcription initiation.

Authors:  M Moyle; J S Lee; W F Anderson; C J Ingles
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

Review 2.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

3.  Analysis of the genes encoding the largest subunit of RNA polymerase II in Arabidopsis and soybean.

Authors:  M A Dietrich; J P Prenger; T J Guilfoyle
Journal:  Plant Mol Biol       Date:  1990-08       Impact factor: 4.076

4.  Modification of RNA polymerase IIO subspecies after poliovirus infection.

Authors:  L M Rangel; C Fernandez-Tomas; M E Dahmus; P Gariglio
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Mutations in RNA polymerase II enhance or suppress mutations in GAL4.

Authors:  L A Allison; C J Ingles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro.

Authors:  W A Zehring; J M Lee; J R Weeks; R S Jokerst; A L Greenleaf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Transcription elongation factor SII interacts with a domain of the large subunit of human RNA polymerase II.

Authors:  J Rappaport; K Cho; A Saltzman; J Prenger; M Golomb; R Weinmann
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  An RNA polymerase II transcription factor inactivated in poliovirus-infected cells copurifies with transcription factor TFIID.

Authors:  S Kliewer; A Dasgupta
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

9.  Interplay of positive and negative effectors in function of the C-terminal repeat domain of RNA polymerase II.

Authors:  Y Li; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

10.  Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III.

Authors:  M Hirakata; Y Okano; U Pati; A Suwa; T A Medsger; J A Hardin; J Craft
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.